CompletedPhase 1ACTRN12605000468628
A pharmacokinetic study to assess the comparative bioavailability of 17-B-estradiol from Metered-Dose Transdermal Sprays (MDTS) and Estraderm 50 patches as hormone replacement therapy in postmenopausal women.
Sponsor
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
Enrollment
12 participants
Start Date
Feb 21, 2000
Study Type
Interventional
Conditions
Eligibility
Sex: FemalesMin Age: 18 Yearss
Inclusion Criteria1
- Healthy post-menopausal women
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Estradiol Metered-Dose Transdermal Sprays (MDTS) vs Estraderm 50 patches for 6-days.
Estradiol Metered-Dose Transdermal Sprays (MDTS) vs Estraderm 50 patches for 6-days.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000468628